cholest-5-ene-3 beta,26-diol has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pinkerton, FD; Schroepfer, GJ; Spilman, CH; Via, DP | 1 |
| Budai, K; Javitt, NB | 1 |
2 other study(ies) available for cholest-5-ene-3 beta,26-diol and Liver Neoplasms
| Article | Year |
|---|---|
Differing effects of three oxysterols on low density lipoprotein metabolism in HepG2 cells.
Topics: Carcinoma, Hepatocellular; Cholestenones; Humans; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Lipoproteins, LDL; Liver Neoplasms; Molecular Structure; Tumor Cells, Cultured | 1993 |
Cholesterol and bile acid synthesis in Hep G2 cells. Metabolic effects of 26- and 7 alpha-hydroxycholesterol.
Topics: Bile Acids and Salts; Carcinoma, Hepatocellular; Cell Line; Chenodeoxycholic Acid; Cholesterol; Cholic Acids; Humans; Hydroxycholesterols; Liver Neoplasms | 1989 |